Skip to main content

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

LXEO holding history

Lexeo Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LXEO overviewAll 13F holders of LXEOFull Q2 2026 holdings

Shares (Q2 2026)
19,866
Value
$92.5K
% of portfolio
<0.1%
Quarters held
4
Since Q3 2025
Holdings of LXEO by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202619,866$92.5K<0.1%−10,611−34.8%ReducedHolders
Q1 202630,477$174.9K<0.1%−449,728−93.7%ReducedHolders
Q4 2025480,205$4.77M<0.1%+467,387+3,646.3%AddedHolders
Q3 202512,818$85.1K<0.1%+12,818NewHolders